BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 13, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 10, 2005
View Archived Issues
GSK report on a novel agonist of LXRalpha and -beta
Read More
Octaparin exerts antithrombotic effect without impairment of hemostasis in animal models
Read More
Pharmacokinetics/pharmacodynamics of oral direct thrombin inhibitor TGN-167
Read More
Clinical evidence supports the use of tecadenoson in the management of PSVT
Read More
TA-CD shows efficacy in reducing drug use in cocaine-dependent subjects
Read More
Product highlights at Serono
Read More
NGX-267 for Alzheimer's disease enters phase I study
Read More
Solvay and Mayo Clinic collaborate on gastrointestinal motility disorders
Read More
NexBio receives SBIR grant for Fludase testing
Read More
Ark reports breakthrough in targeted gene therapy delivery
Read More
Genelabs advances two nonnucleoside compounds for HCV
Read More
Bicifadine begins new phase III trial for postoperative pain
Read More
Preclinical and clinical study data presented on novel antiplatelet agent CS-747
Read More
Interim safety results of pivotal study of NX-1207 for BPH
Read More
Positive phase II results for ICX-PRO advance program into phase III
Read More
Valortim cleared for phase I study
Read More
Isis and Lilly extend antisense drug discovery collaboration
Read More
TH-070 begins phase III study for BPH
Read More
Phase I study of ARRY-334543 in cancer patients cleared to begin
Read More
New phase I antiviral study of Tarvacin for HCV
Read More
Inflazyme receives FDA feedback on phase III studies for IPL-512602
Read More
Tanogitran demonstrates a superior efficacy profile than melagatran in vitro
Read More
CT-011 shows promise in the management of advanced hematological malignancies
Read More
Recent patents disclose novel analgesic and anesthetic agents
Read More
New anti-HIV agents described in recent Pfizer patent
Read More
Novel agents for metabolic disorders in early development
Read More
New DPP-IV inhibitors emerge from Glenmark R&D
Read More